You are here
Mace L Rothenberg
As Chief Medical Officer of Pfizer, Mace Rothenberg leads Pfizer’s Worldwide Medical & Safety organization that is responsible for ensuring that patients, physicians, and regulatory agencies are provided with information on the safe and appropriate use of Pfizer medications. Dr. Rothenberg is also a member of Pfizer’s Portfolio Strategy and Investment Committee, Worldwide Research, Development, and Medical Leadership Team, and Blueprint Leaders Forum. Outside of his responsibilities at Pfizer, Dr. Rothenberg co-chairs the Life Sciences Consortium of the CEO Roundtable on Cancer and is a member of the NYU School of Medicine’s Alumni Board of Governors.
Prior to becoming Pfizer’s CMO, Dr. Rothenberg was Head of Clinical Development & Medical Affairs for Oncology from 2008 to 2016 and Chief Development Officer for Oncology from 2016 to 2018, During that period, Dr. Rothenberg’s organization was responsible for the successful development and regulatory approval of 11 new cancer medicines. Prior to joining Pfizer, Dr. Rothenberg spent 25 years in academia where he focused on early-stage drug development, clinical trial design, and the coordinated laboratory-clinical evaluation of new therapies for gastrointestinal cancers.
Dr. Rothenberg is the recipient of the first Craig Saxton Lifetime Achievement Award from Pfizer, the Lane W. Adams Quality of Life Award from the American Cancer Society honoring him as one of the nation's top cancer caregivers, and the Statesman Award from the American Society of Clinical Oncology honoring him for more than 20 years of service to the organization, the specialty of oncology and cancer patients. He is a Fellow of the American College of Physicians and the American Society of Clinical Oncology.
Dr. Rothenberg received his BA magna cum laude from the University of Pennsylvania in 1978 and his MD from the New York University School of Medicine in 1982. He received his post-graduate training in Internal Medicine at Vanderbilt University and in Medical Oncology at the National Cancer Institute. Dr. Rothenberg served on the faculties of the University of Texas Health Science Center–San Antonio (1991-1998) and Vanderbilt University (1998-2008).